Sec Form 3 Filing - LIVERIS ANDREW N @ DowDuPont Inc. - 2017-08-31

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person LIVERIS ANDREW N 2. Issuer Name and Ticker or Trading Symbol DowDuPont Inc. [ DWDP] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner _____ Officer (give title below) X __ Other (specify below) Executive Chairman (Last) (First) (Middle) C/O THE DOW CHEMICAL COMPANY, 2030 DOW CENTER 3. Date of Earliest Transaction (MM/DD/YY) 08/31/2017 (Street) MIDLAND, MI48674 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 649,936.089 ( 1 ) D Common Stock 1,686.7065 I By 401(k) Plan Common Stock 3,673.8586 I By 401(k) Plan ESOP Common Stock 821,324.5 I By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4 ) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Non-Qualified Stock Option (Right to Buy) $ 9.53 ( 2 ) 02/13/2019 Common Stock 909,100 D Non-Qualified Stock Option (Right to Buy) $ 27.79 ( 2 ) 02/12/2020 Common Stock 551,800 D Non-Qualified Stock Option (Right to Buy) $ 32.16 ( 2 ) 02/15/2023 Common Stock 761,660 D Non-Qualified Stock Option (Right to Buy) $ 34 ( 2 ) 02/10/2022 Common Stock 516,000 D Non-Qualified Stock Option (Right to Buy) $ 38.38 ( 2 ) 02/11/2021 Common Stock 412,380 D Non-Qualified Stock Option (Right to Buy) $ 38.62 ( 2 ) 02/15/2018 Common Stock 619,370 D Non-Qualified Stock Option (Right to Buy) $ 46.01 ( 3 ) 02/12/2026 Common Stock 331,510 D Non-Qualified Stock Option (Right to Buy) $ 46.71 ( 2 ) 02/14/2024 Common Stock 315,930 D Non-Qualified Stock Option (Right to Buy) $ 49.44 ( 4 ) 02/13/2025 Common Stock 312,670 D Non-Qualified Stock Option (Right to Buy) $ 61.19 ( 5 ) 02/10/2027 Common Stock 263,860 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other LIVERIS ANDREW N C/O THE DOW CHEMICAL COMPANY 2030 DOW CENTER MIDLAND, MI48674 Executive Chairman Signatures /s/ Andrew N. Liveris 09/11/2017 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Total includes deferred shares of Common Stock to be delivered in one installment on or about each of the following dates, contingent upon employment: 61,190 shares on February 13, 2018; 66,750 shares on February 12, 2019; 51,890 shares on February 10, 2020. Total also includes deferred shares of Common Stock converted from performance based awards not previously reportable on Table I or II, to be delivered in one installment on or about each of the following dates, contingent upon employment: 164,109 shares on February 13, 2018; 142,020 shares on February 12, 2019; and 127,958 shares on February 13, 2020. ( 2 )This option is fully vested and exercisable. Option shares may be used to satisfy withholding taxes. ( 3 )One-third of this option is exercisable. The remaining two-thirds will vest in two equal installments on February 12, 2018 and February 12, 2019. Option shares may be used to satisfy withholding taxes. ( 4 )Two-thirds of this option is exercisable. The remaining one-third will vest on February 13, 2018. Option shares may be used to satisfy withholding taxes. ( 5 )This option will vest in three equal installments beginning on February 10, 2018. Option shares may be used to satisfy withholding taxes.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.